Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
05/2010
05/20/2010US20100124547 Compositions and methods for inhibiting expression of factor vii genes
05/20/2010CA2766246A1 Genetic variants underlying human cognition and methods of use thereof as diagnostic and therapeutic targets
05/20/2010CA2758687A1 Compositions, kits and methods for detection of campylobacter nucleic acid
05/20/2010CA2743505A1 Gene knockout mesophilic and thermophilic organisms, and methods of use thereof
05/19/2010EP2186910A2 Methods and compositions for improved luminescence assays using microparticles
05/19/2010EP2186897A1 An improved method for synthesising templated molecules
05/19/2010EP2186801A2 Intermediates for synthesizing dibenzorhodamine dyes
05/19/2010EP2185723A1 Genetic variation in pro-melanin-concentrating hormone gene affects carcass traits in cattle
05/19/2010EP2185707A2 Cell permeable nm23 recombinant proteins, polynucleotides encoding the same, and anti-metastatic composition comprising the same
05/19/2010EP2185574A2 Antibodies and related molecules that bind to 24p4c12 proteins
05/19/2010EP2185573A2 Highly visible chromosome-specific probes and related methods
05/19/2010EP1759013B1 Identification of surface-associated antigens for tumor diagnosis and therapy
05/19/2010EP1540010B1 Use of biomarkers for detecting ovarian cancer
05/19/2010EP1483029B1 Selective elution of immobilized multiplexed primer extension products
05/19/2010EP1448584B1 Mutated anti-cd22 antibodies with increased affinity to cd22-expressing leukemia cells
05/19/2010EP1214097B9 Nucleic acids encoding polyepitope polypeptides
05/19/2010EP0888374B1 HIGH AFFINITY NUCLEIC ACID LIGANDS OF THE COMPLEMENT SYSTEM PROTEIN C1q
05/19/2010CN101711164A Synthetic mini/micro-dystrophin genes to restore nnos to the sarcolemma
05/19/2010CN101037688B Small molecule interfering RNA and its anti-tumor use
05/18/2010US7718870 Plants and seeds of hybrid corn variety CH771816
05/18/2010US7718869 Plants and seeds of hybrid corn variety CH355718
05/18/2010US7718868 Plants and seeds of corn variety CV319521
05/18/2010US7718859 Plants and seeds of corn variety CV391950
05/18/2010US7718855 Inbred corn line SY0705W
05/18/2010US7718850 Methods and means for delaying seed shattering in plants
05/18/2010US7718790 1st and 2nd primer sets provide a first detectable signal on the occurrence of amplification of mitochondrial nucleic acid and second signal on the occurrence of amplification of host nuclear nucleic acid; probe comprising a 6-carboxyfluorescein reporter, 5-carboxytetramethylrhodamine quencher molecule
05/18/2010US7718789 Compositions and methods for the modification of gene expression
05/18/2010US7718787 Gene families associated with cancers
05/18/2010US7718786 Process for obtaining recombined nucleotide sequences in vitro, libraries of sequences and sequences thus obtained
05/18/2010US7718785 Mutations in the SLC40A1 gene associated to impaired iron homeostasis
05/18/2010US7718784 RNA/DNA chimera comprising a fluorophore-quencher pair and a nucleic acid construct; for rapid screening of interactions between the HIV-1 nucleocapsid protein, NCp7, and a stem-loop region, SL3, of the HIV-1 RNA, or antagonists
05/18/2010US7718783 cDNA molecule of a mammalian ELF3 gene; associated with cancer, including ELF3 mRNA intron retention, a novel ELF3 5' untranslated region, and a novel Alu, Alukwd
05/18/2010US7718770 PRO1305-polypeptides
05/18/2010US7718632 RNAi inhibition of alpha-ENaC expression
05/18/2010US7718631 For treating p53 containing cancer
05/18/2010US7718630 Using RNA interference to reduce notch ligand Delta protein expression; diagnosis and treatment of cell proliferative disorders
05/18/2010US7718629 double-stranded ribonucleic acid comprises a sense strand first sequence and an antisense strand second sequence; modified; as a biodrug for treating diseases caused by Eg5 expression; as anticarcinogenic agent for treating cancer; selectively and efficiently silence the Eg5 gene
05/18/2010US7718628 modified oligonucleotide for gene therapy; as antitumor agent, anticarcinogenic agent; Inhibiting synthesis and function; arresting cellular proliferation
05/18/2010US7718625 Polynucleotides targeted against the extended 5′-UTR region of argininosuccinate synthase and uses thereof
05/18/2010US7718624 biodrug delivery a nucleic acid for treating bacterial infection or viral infection; reverse transcriptase enzyme inhibitor; sepsis, septic shock, encephalitis, meningitis, acute respiratory distress syndrome, severe acute respiratory syndrome, tuberculosis, lyme disease, HIV infection
05/18/2010US7718623 Immunostimulatory oligonucleotide that induces interferon alpha
05/18/2010US7718622 freezing dried biochemical conjugated immunomodulator comprising immunostimulatory polynucleotide sequence and plant Ragweed allergen; genetic vaccines
05/18/2010US7718575 Method of selecting HLA-DP4 ligands and the applications thereof
05/18/2010US7718432 Non-immunogenic, hydrophilic/cationic block copolymers and uses thereof
05/18/2010US7718431 PUFA polyketide synthase systems and uses thereof
05/18/2010US7718424 AAV4 vector and uses thereof
05/18/2010US7718413 Secretase for use in identifying modulator for treatment and prevention of alzheimers disease; Beta-site amyloid precursor protein cleaving enzyme (BACE)
05/18/2010US7718411 Recombinant Clan C hydrolase for use in cleaning agents, textile treatment and enhancement of animal feeds; directed protein evolution
05/18/2010US7718408 Method
05/18/2010US7718404 producing cyclotetrasaccharide of glucose units; use as filler, stabilizer, sweetener among other things in drugs, cosmetics and foods
05/18/2010US7718400 for increasing insulin sensitivity; decreasing the dose of insulin required for the treatment of diabetes; controlling serum glucose levels; increasing lean tissue mass; increasing overall body strength; and regulating bone resorption
05/18/2010US7718397 Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
05/18/2010US7718396 Inducible high expression system
05/18/2010US7718383 Human T2R65 taste receptor and related assays for identifying human bitter taste modulators
05/18/2010US7718374 Probes for continuous monitoring of replication; solid phase synthesis; distinguishing in a sample between wild-type, mutant and heterozygous target polynucleotides
05/18/2010US7718373 Canola event PV-BNGT04(RT73) and compositions and methods for detection thereof
05/18/2010US7718372 Using mutations in regulatory sequences of prostate specific antigen as diagnostic tool in detection of cell proliferative disorders; identifying a subject at risk for increased cellular PSA production and/or prostate cancer by detecting the presence or absence of a genetic polymorphism in the prostate
05/18/2010US7718371 Method and apparatus for isolating and purifying nucleic acid using a single surface
05/18/2010US7718370 Determining the sequence of alleles of a locus of interest, and quantitating a ratio for the alleles at the locus of interest, wherein the ratio indicates the presence or absence of a chromosomal abnormality; noninvasive; determining the sequence of DNA from a fetus
05/18/2010US7718369 Recurrent gene fusions in prostate cancer
05/18/2010US7718367 Predicting preeclaimpsia in a pregnant woman, trisomy 18 and trisomy 21 in a fetus; by quantitatively measuring in the maternal blood the amount of one or more RNA species derived from a set of genetic loci and comparing the amount of the RNA species with a standard control
05/18/2010US7718366 Methods and compositions relating to COL2A1 gene mutations and osteonecrosis
05/18/2010US7718365 Microarray analysis of RNA
05/18/2010US7718364 for assessing allelic losses and hypermethylation of genes in CpG tumor promotor region on specific chromosomal regions in cancer patients, including melanoma, neuroblastoma breast, colorectal, and prostate cancer patients
05/18/2010US7718361 detecting the presence of a bacterial pathogen by isolating nucleic acid from the sample, quantifying the amount of nucleic acid comprising a preselected sequence specific for bacterial pathogen, and determining whether the amount of nucleic acid exceeds a first predetermined cut off value
05/18/2010US7718183 Proteins with repetitive bacterial-Ig-like (big) domains present in Leptospira species
05/18/2010US7718182 Using alkyl hydroperoxide reductase as tool in developing vaccines to prevent and treat microorganismal infection; immunotherapy
05/18/2010US7718180 Immunizing compositions comprising nucleic acids encoding the HIV-1 matrix protein myristate binding site
05/18/2010US7718173 Anti-pro6094 antibodies
05/18/2010CA2422599C Gibberellin 2-oxidase gene, functions and uses thereof
05/18/2010CA2318581C Force discrimination assay
05/18/2010CA2302808C 50 human secreted proteins
05/18/2010CA2216717C Compositions for the diagnosis, prevention, and treatment of tumor progression
05/14/2010WO2010054331A1 Microrna-mediated regulation of ubc9 expression in cancer cells
05/14/2010WO2010054273A1 Treatment of restless leg syndrome and sleep disorders
05/14/2010WO2010054267A1 Immunosuppression compound and treatment method
05/14/2010WO2010054051A1 Erbb-3 (her3)-selective combination therapy
05/14/2010WO2010054004A2 Nucleic acid extraction on curved glass surfaces
05/14/2010WO2010053978A2 Modulation of toll-like receptor 5 expression by antisense oligonucleotides
05/14/2010WO2010053971A1 Modulation of toll-like receptor 2 expression by antisense oligonucleotides
05/14/2010WO2010053518A2 Methods and compositions for inactivating glutamine synthetase gene expression
05/14/2010WO2010051639A1 Use of mir-126 for enhancing hematopoietic stem cell engraftment, for isolating hematopoietic stem cells, and for treating and monitoring the treatment of acute myeloid leukemia
05/14/2010WO2010051632A1 Syngap1 dysfunctions and uses thereof in diagnostic and therapeutic applications for mental retardation
05/14/2010WO2010033773A3 Diagnostic, prognostic and therapeutic uses of mirs in adaptive pathways and/or disease pathways
05/14/2010WO2010019847A3 Aptamer inhibition of thrombus formation
05/14/2010WO2010017264A3 Photo-crosslinked nucleic acid hydrogels
05/14/2010CA2742991A1 Microrna-mediated regulation of ubc9 expression in cancer cells
05/14/2010CA2742598A1 Nucleic acid extraction on curved glass surfaces
05/14/2010CA2742597A1 Modulation of toll-like receptor 4 expression by antisense oligonucleotides
05/14/2010CA2742596A1 Modulation of toll-like receptor 2 expression by antisense oligonucleotides
05/14/2010CA2742531A1 Modulation of toll-like receptor 5 expression by antisense oligonucleotides
05/14/2010CA2742281A1 Immunosuppression compound and treatment method
05/14/2010CA2741050A1 Erbb-3 (her3)-selective combination therapy
05/13/2010US20100122384 Nucleic Acid Molecules and Other Molecules Associated with Plants
05/13/2010US20100122382 Cell Cycle Genes and Related Methods
05/13/2010US20100122380 Polypeptides having feruloyl esterase activity and polynucleotides encoding same
05/13/2010US20100122377 Lunaria annua,cardamine graeca and teesdalia nudicaulis fae genes and their use in producing nervonic and eicosenoic acids in seed oils
05/13/2010US20100122373 Nucleic acid molecules and other molecules associated with plants
05/13/2010US20100122365 Optimizing glycan processing in plants
05/13/2010US20100122363 Certain human genomic DNA associated with total red-green colorblindness
1 ... 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 ... 899